Ligand Pharmaceuticals
LGND
LGND
256 hedge funds and large institutions have $1.95B invested in Ligand Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 107 increasing their positions, 62 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 241 → 256 (+15)
2.64% less ownership
Funds ownership: 99.13% → 96.49% (-2.6%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
256
Holding in Top 10
1
Calls
$3.56M
Puts
$567K
Top Buyers
| 1 | +$29.7M | |
| 2 | +$12.3M | |
| 3 | +$9.72M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$7.18M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$4.4M |
Top Sellers
| 1 | -$20.6M | |
| 2 | -$20.1M | |
| 3 | -$8.72M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$7.77M |
| 5 |
BlackRock
New York
|
-$5.74M |